PLC Cross-border Life Sciences Handbook
China - Compensation for Drug and Device-Related Injuries
2008/09
As China develops into one of the leading manufacturers for pharmaceutical and medical device products in the world, it must increasingly contend with what other nations have encountered over the past decades: finding the right way to compensate patients when they suffer from injuries that may have been related to the use of a drug or device product.
©This article was first published in the PLC Cross-border Life Sciences Handbook 2008/09 and is reproduced with the permission of the publisher, Practical Law Company.
©This article was first published in the PLC Cross-border Life Sciences Handbook 2008/09 and is reproduced with the permission of the publisher, Practical Law Company.
Contacts
Capabilities
Suggested News & Insights
Digitalization Instructions for Use EU Issues Updated Framework for eIFUs of Medical DevicesMay 19, 2021NICE Moves to Drive UK Digital Health InnovationMay 17, 2021EU Publishes Guidance on Clinical Investigations to Help Sponsors’ Compliance with MDRMay 5, 2021Statutory Change to New Chemical Entity Exclusivity Provision May Have Impacts for Scope of Patent Term ExtensionApril 30, 2021FDA Releases Guidance on Remote Interactive Evaluations During COVID-19April 21, 2021FDA’s COVID-19 Facility Inspection Backlog: Likely Reinspection Delays Emphasize Importance of Facility ReadinessApril 14, 2021
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory